
COOPER COS INC/THE
COONASDAQTrading Snapshot
- Day Range
- $187.93 β $192.05
- 52-Week Range
- $58.89 β $89.83
- Volume
- $3.17B
- Avg Volume
- $2.34B
- Shares Outstanding
- 195.0M
- Next Earnings
- Oct 23, 2026
Fundamentals Snapshot
- Annual Revenue
- $4.09B
- Last Q Revenue
- $1.08B
- P/E Ratio
- 63.1
- P/S Ratio
- 3.5x
- EPS (TTM)
- $1.18
- Dividend Yield
- 0.00%
Why Investors Own COO
- βHigh-growth profile β revenue up +41.9% YoY with expanding US Equity exposure.
- βHealthy economics β 79% gross margin and 23% free-cash-flow margin.
- βNew products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
Financial Trends
About COOPER COS INC/THE
The Cooper Companies, Inc. (COO) operates as a global medical device firm, primarily focused on developing, producing, and distributing products through two distinct business units: CooperVision and CooperSurgical. CooperVision specializes in contact lenses. Their product range includes spherical lenses for common vision issues like nearsightedness and farsightedness, as well as advanced lenses such as toric for astigmatism, multifocal for presbyopia, and specialized options addressing myopia, dry eyes, and eye fatigue. These vision correction solutions are available across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region. Meanwhile, CooperSurgical is dedicated to women's and family health, providing a wide array of medical devices, fertility treatments, genetic testing, diagnostic tools, and contraceptives to healthcare providers and patients globally. This segment's offerings encompass various surgical and office-based products like PARAGARD (an IUD), uterine manipulators, retractors, and closure devices. It also delivers comprehensive fertility services, including specialized consumables, equipment, embryo services, and preimplantation genetic screening. Established in 1958, The Cooper Companies, Inc. is headquartered in San Ramon, California.
Otter Score Breakdown
βAnalyst Price Target
βLatest News & Updates
COOPER COS INC/THE tops quarterly estimates as demand accelerates
Revenue grew double digits with management guiding above consensus; margins continued to expand.
Analysts lift COO price targets on improving margins
Several firms raised targets, citing stronger free cash flow and a healthier backlog.
COOPER COS INC/THE announces new agreement to expand its footprint
The move broadens the companyβs reach and could add incremental revenue over the next year.